CXCR4 CCR9 CAR-T therapy (The First Affiliated Hospital of Soochow University)

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameCXCR4 CCR9 CAR-T therapy (The First Affiliated Hospital of Soochow University)

Drug Alias NameU69-CART-Cells therapy (The First Affiliated Hospital of Soochow University)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacementsC-X-C motif chemokine receptor 4 modulatorsC-C chemokine receptor type 9 modulators

TargetsC-X-C motif chemokine receptor 4C-C chemokine receptor type 9

Therapy Area/IndicationsLeukemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesThe First Affiliated Hospital Of Soochow University

China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Soochow University

Inactive CompaniesN/A

Active IndicationsLeukemia

Inactive IndicationsN/A

Other Information

ATC CodeN/A